期刊文献+

兔VX_2肝癌模型纳米磁微粒栓塞热疗初步研究 被引量:4

Hyperthermia after nano magnetic particles embolization VX_2 rabbit liver tumor model
原文传递
导出
摘要 目的:观察磁性微粒栓塞热疗对 VX2兔肝癌的疗效。方法40只大白兔制成 VX2模型后等分成四组:对照组(A组)、碘油栓塞组(B组)、碘油+磁性微粒组(C组)、磁热疗组(D组)。制备肿瘤模型后14 d,B、C、D组经股动脉逆行插管行肝动脉造影及栓塞。栓塞后第2天,B组3只和D组全部动物于振荡磁场(alternating magnetic field,AMF)下接受磁热疗,实时测定动物肿瘤中心、肿瘤边缘及正常肝组织3个部位温度变化。治疗前后查血常规、肝肾功能。治疗后14 d处死全部动物,开腹观察肿瘤情况并行病理检查。结果治疗前四组肿瘤体积分别为(1.6±1.5)、(2.5±2.5)、(2.7±1.6)、(3.5±2.6)cm3,各组肿瘤大小差异无统计学意义(F=1.247,P=0.308)。AMF下,B组3个部位平均温度与磁热疗前相应部位温度比较差异无统计学意义(F 瘤心=0.01, P 瘤心=0.981;F 瘤缘=0.618,P 瘤缘=0.476;F 正常肝=0.217,P 正常肝=0.665);D组3个部位热疗前温度分别为(35.4±1.7)、(35.9±1.8)、(36.1±1.4)℃,差异无统计学意义(F=1.038,P=0.413);热疗开始后7~26 min D组肿瘤中心及边缘温度与B组相应部位及D组正常肝组织的温度差异有统计学意义(FB-D 瘤心=5.431,PB-D 瘤心=0.041;FB-D 瘤缘=9.744,PB-D 瘤缘=0.011;FD 组3个部位=8.379, PD组3个部位=0.002);D组肿瘤边缘温度最高可达46℃。术后14 d,四组肿瘤体积分别为(31.4±20.6)、(26.7±18.2)、(28.7±9.1)、(25.8±13.9)cm3,各组之间差异无统计学意义(F=0.218,P=0.883),但D组肿瘤体积最小。血常规、肝肾功能于治疗后7d恢复正常水平。结论经肝动脉磁性微粒栓塞后磁热疗治疗VX2兔肝脏肿瘤是安全可行的,可进一步深入研究。 Objective To observe the effect of hyperthermia and the influence of heat to surrounding organs of VX2 rabbit liver cancer model exposed to alternating magnetic field after embolized with nanomagnetic particles. Methods 40 rabbits with VX2 tumor were divided into four groups equally. Group A as control group receive no treatment, group B embolized with lipiodol embolization only, group C embolized with lipiodol plus magnetic particles and group D exposed to alternating magnetic field after embolized with lipiodol plus nanomagnetic particles. 14 days after the tumor transplanted, opened the abdomen to observe the size and shape of the tumor. Then trans-femoral retrograde approach of hepatic arterial catheterization was used in group B, C and D to do angiography and embolization. The next day, three models of group B and all of group D were exposed to alternating magnetic field, the temperature in the center of tumor, the edge of tumor and normal liver parenchyma were measured simultaneously. Venous blood of each animal was get just before the operation, the blood routine and the function of liver and kidney was examined. 14 days later, all animals will be killed to observe the change of tumor in the liver and the condition of the abdomen, the pathology examination will also be done. Results The volume of tumor among four groups[(1.6±1.5), (2.5±2.5), (2.7±1.6), (3.5±2.6)cm3] had no significant difference before operation (F=1.247, P=0.308). The three different positions temperature of group B under AMF had no significant difference compared to pre-operation temperature (Fcenter=0.01, Pcenter=0.981; Fedge=0.618, Pedge=0.476; Fnormol=0.217, Pnormal=0.665). Three points basic temperature of group D (35.4±1.7 ℃, 35.9±1.8℃and 36.1±1.4℃) was without significant difference (F=1.038, P=0.413). 7 to 26 minutes after hyperthermia, the center and the edge temperature of tumor in group D had significant difference with corresponding positions of group B and liver parenchyma of group D(FB-D center=5.431, PB-D center=0.041;FB-D edge=9.744, PB-D edge=0.011; FD =8.379, PD=0.002). The highest temperature at the edge of tumor of group D could be reach 46℃. 14 days later, the tumor volume of 4 groups was (31.4±20.6), (26.7±18.2), (28.7±9.1), (25.8±13.9)cm3 respectively, which without significant difference with each other (F=0.218, P=0.883), but the tumor volume of Group D was the smallest. The blood routine and liver function restored to normal seven days after therapy. Conclusions It is feasible to cure the VX2 tumor under an alternating magnetic field after nanomagnetic particles embolization without significant effect on surrounding normal liver parenchyma.
出处 《中华临床医师杂志(电子版)》 CAS 2014年第18期101-107,共7页 Chinese Journal of Clinicians(Electronic Edition)
关键词 高温 诱发 碘化油 肝细胞 模型 动物 纳米磁微粒 Hyperthermia, induced Iodized oil Carcinoma, hepatocellular Models,animal Ferromagnetic nanoparticles
  • 相关文献

参考文献18

  • 1Moroz P,Jones SK,Gray BN.Magnetically mediated hyperthermia:current status and future directions[J].Int J Hyperthermia,2002,18(4):267-284.
  • 2Kozissnik B,Bohorquez AC,Dobson J,et al.Magnetic fluid hyperthermia:advances,challenges,and opportunity[J].Int J Hyperthermia,2013,29(8):706-714.
  • 3周承凯,梁惠民,李欣,柳曦.实验兔VX2肝肿瘤模型制作及动脉插管技术探讨[J].介入放射学杂志,2006,15(2):101-104. 被引量:33
  • 4Kawashita M,Tanaka M,Kokubo T,et al.Preparation of ferrimagnetic magnetite microspheres for in situ hyperthermic treatment of cancer[J].Biomaterials,2005,26(15):2231-2238.
  • 5Moroz P,Jones SK,Gray BN.Tumor response to arterial embolization hyperthermia and direct injection hyperthermia in a rabbit liver tumor model[J].J Surg Oncol,2002,80(3):149-156.
  • 6颜士岩,张东生,郑杰,顾宁,王子妤,杜益群,倪海燕,刘东风,张晓明.Fe_2O_3纳米磁流体热疗治疗肝癌[J].中华实验外科杂志,2004,21(12):1443-1446. 被引量:30
  • 7王煦漫,古宏晨,杨正强,王建华.磁热疗用Fe_3O_4在交变磁场中的热效应[J].上海交通大学学报,2005,39(2):275-278. 被引量:16
  • 8杨正强,王建华,王煦漫,古宏晨,庞乾骏.纳米超顺磁性碘油肝动脉栓塞热疗VX2兔肝肿瘤的实验研究[J].中华放射学杂志,2006,40(8):870-874. 被引量:8
  • 9Moroz P,Jones SK,Gray BN.The effect of tumour size on ferromagnetic embolization hyperthermia in a rabbit liver tumour model[J].Int J Hyperthermia,2002,18(2):129-140.
  • 10Lu AH,Salabas EL,Schüth F.Magnetic nanoparticles:synthesis,protection,functionalization,and application[J].Angew Chem Int Ed Engl,2007,46(8):1222-1244.

二级参考文献32

  • 1许荣德,周泽健,邵培坚,罗鹏飞,李伟科,栾建华,庄文行.经肝动脉栓塞化疗与激光消融术联合治疗原发性肝癌[J].中华放射学杂志,2004,38(6):587-591. 被引量:9
  • 2Hilger I, Fruhauf K, Andra W, et al. Heating potential of iron oxide for therapeutic purposes in interventional radiology [J]. Academic Radiology, 2002,9:198-202.
  • 3Hiergeist R, Andra W, Buske N, et al. Application of magnetite ferrofluids for hyperthermia[J]. Journal of Magnetism and Magnetic Materials, 1999,201:420-422.
  • 4Chan D C, Kirpokin D, Bunn P A, et al. Scientific and clinical applications of magnetic carriers [M].New York: Plenum Press, 1997.
  • 5Moroz P, Jones S K, Pardoe H, et al. Tumor response tOarterial embolization hyperthermia and direct injection hyperthermia in a rabbit liver tumor model [J]. Surgical Oncology, 2002,80:149-156.
  • 6Jordan A, Scholz R, Wust P, et al. Endocytosis of dextran and silane-coated magnetite nanoparticles and the effect of intracellular Hyperthermia on human mammary carcinoma cells in vitro[J]. Journal of Magnetism and Magnetic Materials, 1999, 194:185-196.
  • 7Mitsumori M, Hiraoka M, Shibata T, et al. Targeted Hyperthermia using Dextran magnetic complex:a new treatment modality for liver tumours[J]. Hepato-Gastroenteroiogy, 1996,43(12):1431-1437.
  • 8Chan D C, Kirpokin D, Bunn P A, et al. Synthesis and evaluation of colloidal magnetic iron oxide for the site-specific radiofrequency-induced hyperthermia of cancer[J]. Journal of Magnetism and Magnetic Materials, 1993,122: 374- 378.
  • 9Rosensweig R E. Heating magnetic fluid with alternating magnetic field[J]. Journal of Magnetism and Magnetic Materials, 2002,252: 370-374.
  • 10Landau L D, Lifshitz E M. Electrodynamics of continuous media[M]. Oxford: Pergamon Press, 1960.

共引文献83

同被引文献60

  • 1陈昆涛,何健垣,刘建民,郭瑞珍.影像实验研究中兔VX_2肝癌模型制作的完善及综合评价[J].实用医技杂志,2006,13(20):3607-3610. 被引量:4
  • 2贾洪顺,全显跃,孙涛.兔VX_2肝癌MRI征象与病理对照研究[J].实用放射学杂志,2007,23(9):1254-1257. 被引量:3
  • 3Nitta N, Sonoda A, Seko A, et al. A combination of cisplatin-eluting gelatin microspheres and flavopiridol enhances anti-tumour effects in a rabbit VX2 liver tumour model. Br J Radiol. 2010;83:428-432.
  • 4Deng J, Virmani S, Yang GY, et al. lntraprocedural diffusion-weighted PROPELLER MRI to guide percutaneous biopsy needle placement within rabbit VX2 liver tumors. J Maon Reson Imaoina. 2009:30:366-373.
  • 5Matsumua T, Moriyau F, Kono Y, et al. Contrast-enhanced power Doppler imaging of the liver-preliminary animal study. Nippon Rinsho. 1998;56:985-989.
  • 6Kievit FM, Veiseh O, Fang C J, et al. Chlorotoxin labeled magnetic nanovectors for targeted gene delivery to glioma. ACS Nano. 2010;4(8):4587-4594.
  • 7Veiseh M, Gabikian P, Bahrami SB, et al. Cy5.5 bioconjugate for intraoperative visualization of cancer loci. Cancer Res. 2007;67(14):6882-6888.
  • 8Veiseh O, kievit FM, Fang C J, et al. Chlorotoxin bound magnetic nanovector tailored for cancer cell targeting, imaging, and siRNA delivery. Biomaterials. 2010;31(31): 8032-8042.
  • 9Mok H, Zhang H. Superparamagnetic iron oxide nanoparticle- based delivery systems for biotherapeutics. Expert Opin Drug De- liv, 2013, 10(1) :73-87.
  • 10Hayashi K, Nakamura M, Sakamoto W, et al. Superparamagnet- ic nanoparticle clusters for cancer thernostics combining magnetic resonance imaging and hyperthermia treatment. Theranostics, 2013,3(6) : 366-376.

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部